The metallopeptidase neprilysin is a hypoxia-induced prognostic factor in lung adenocarcinoma
K. Leithner, C. Wohlkoenig, E. Stacher, J. Lindenmann, N.A. Hofmann, B. Ebner, F. Quehenberger, F.M. Smolle-Jüttner, S. Philipsen, H.H. Popper, A. Hrzenjak, A. Olschewski, H. Olschewski (Graz, Austria; Rotterdam, Netherlands)
Source: Annual Congress 2012 - Prognosis of lung cancer
Session: Prognosis of lung cancer
Session type: Thematic Poster Session
Number: 4167
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Leithner, C. Wohlkoenig, E. Stacher, J. Lindenmann, N.A. Hofmann, B. Ebner, F. Quehenberger, F.M. Smolle-Jüttner, S. Philipsen, H.H. Popper, A. Hrzenjak, A. Olschewski, H. Olschewski (Graz, Austria; Rotterdam, Netherlands). The metallopeptidase neprilysin is a hypoxia-induced prognostic factor in lung adenocarcinoma. Eur Respir J 2012; 40: Suppl. 56, 4167
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The effect of matrix metalloproteinase-9 and vascular endothelial growth factor expression on survival of non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 324s Year: 2005
Apelin expression is a prognostic factor in non-small cell lung cancer Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010
Bcl-2 as a prognostic factor for survival in small-cell lung cancer Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009
Expression of tumor necrosis factor receptor 2 in human non-small cell lung cancer and its role as a potential prognostic biomarker Source: International Congress 2019 – Biology of lung cancer Year: 2019
Increased vascular-endothelial growth factor a (VEGF-A) expression and response to angiogenesis inhibitor erlotinib in non-small-cell lung cancer (NSCLC) – hint for a new predictive marker? Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology Year: 2007
D104N poluymorphism in endostatin, an angiogenesis inhibitor, in lung cancer susceptibility Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010
Adipocyte-derived exosomes promote lung cancer metastasis byincreasing MMP9 activity via transferring MMP3 to lung cancer cells Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017
Prognostic significance of epidermal growth factor receptor expression in nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 72s Year: 2002
Immunohistochemical studies of COX-2, MMP-9, p53 and VEGF in non-small-cell lung cancer, specifically squamous cell carcinoma and adenocarcinoma Source: Eur Respir J 2006; 28: Suppl. 50, 387s Year: 2006
Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer Source: Eur Respir J 2007; 30: 627-632 Year: 2007
Prognostic role of epidermal growth factor receptor in stage III nonsmall cell lung cancer Source: Eur Respir J 2005; 25: 329-335 Year: 2005
Apoptosis, tumor cell proliferation and angiogenesis as prognostic factor in lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004
MMP expression and abnormal lung permeability are important determinants of outcome in IPF Source: Eur Respir J 2009; 33: 77-84 Year: 2009
Expression of vascular endothelial-cadherin and vascular endothelial growth factor in non-small cell lung cancer and their clinical significances Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012
Angiopoietin-2 as a prognosticator of lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 388s Year: 2006
The prognostic role of matrix metalloproteinase-7 in scleroderma-associated interstitial lung disease Source: Eur Respir J, 58 (6) 2101560; 10.1183/13993003.01560-2021 Year: 2021
Downregulation of Thyroid transcription factor 1 in lung adenocarcinoma: the prognostic impact Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018
Changes and significance of hepatoma-derived growth factor and vascular endothelial growth factor in serum and lung tissue from patients with lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
Investigating new prognostic crossroads in lung carcinomas; comparing the prognostic potential of vascular endothelial growth factor (VEGF) and its receptors versus endoglin (CD105) Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009
Prognostic value of non-angiogenic and angiogenic growth patterns in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 40s Year: 2004